Waning effectiveness of COVID-19 vaccines-Reference-Cited by-同舟云学术

Waning effectiveness of COVID-19 vaccines

Published:2022-02 Issue:10327 Volume:399 Page:771-773
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chemaitelly Hiam,Abu-Raddad Laith J

Publisher

Elsevier BV

Subject

General Medicine

Reference12 articles.

1. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden;Nordström;Lancet,2022

2. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy;Abu-Raddad;EClinicalMedicine,2021

3. Efficacy of natural immunity against SARS-CoV-2 reinfection with the beta variant;Chemaitelly;N Engl J Med,2021

4. A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection;Kojima;Eval Health Prof,2021

5. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar;Chemaitelly;N Engl J Med,2021

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity;Frontiers in Immunology;2024-09-06

2. Assessing Healthy Vaccinee Effect in COVID-19 Vaccine Effectiveness Studies: A National Cohort Study in Qatar;2024-07-29

3. Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 – December 2022;BMC Public Health;2024-07-11

4. Tackling SARS‐CoV‐2: Deep Purpose Virtual Screening Identified Compounds to Target the Glycosylated Full‐Length GRP78;Advanced Theory and Simulations;2024-07-08

5. Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022;Vaccines;2024-06-17